- The policy aims to promote research and innovation in the pharmaceutical and medical technology sector in India, and to make India a global leader in this field. The scheme has an outlay of Rs. 5,000 crore for a period of five years, and has two components:
- Strengthening of research infrastructure through establishment of seven National Institutes of Pharmaceutical Education & Research (NIPERs) as Centres of Excellence (CoEs) in specific specialisations at a tentative cost of Rs. 700 crore.
- The policy and scheme are expected to create a world-class research environment, foster industry-academia collaboration, focus on priority areas, accelerate the growth of the pharmaceutical sector, enhance. India’s share in the global value chain, and improve the quality, accessibility, and affordability of healthcare products and services.
Question:
Q.1 Which ministry launched the National Policy and PRIP Scheme for Pharma-MedTech sector?a. Ministry of Science and Technology
b. Ministry of Chemicals and Fertilizers
c. Ministry of Health and Family Welfare
d. Both B and C
